NDV-HUJ
AXP000117.1 · Oncolytic virus
- Platform
- Newcastle disease virus (HUJ strain, lentogenic)
- Originator
- Hadassah-Hebrew University Medical Center
- Sponsor
- Hadassah-Hebrew University Medical Center
Names
| Name | Type | Source |
|---|---|---|
| NDV-HUJ | preferred name, code | curator, paper |
Virus
- Role
- Oncolytic
- Family
- Paramyxoviridae
- Virus
- Newcastle disease virus (NCBI Taxonomy 2560319)
- Strain
- HUJ (lentogenic)
- Replication
- replicating
- Modifications
- none (lentogenic natural strain)
- Route
- intravenous
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (0)
No trial in the latest ClinicalTrials.gov snapshot names this program.
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 16257582 | Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. | Molecular therapy : the journal of the American Society of Gene Therapy | 2006 | name in title: NDV-HUJ |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 27512670 | Therapeutic potential of oncolytic Newcastle disease virus: a critical review. | Oncolytic virotherapy | 2015 | name in abstract: NDV-HUJ |
| PMID 22622327 | Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity. | The Journal of general virology | 2012 | name in abstract: NDV-HUJ |
| PMID 19864394 | The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin. | Journal of virology | 2010 | name in title: NDV-HUJ |
| PMID 18535620 | Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors. | Cancer gene therapy | 2008 | name in title: NDV-HUJ |
Notes
Lentogenic NDV HUJ strain; phase I/II in recurrent glioblastoma multiforme. Academic programme; no current sponsor found.
How to cite
NDV-HUJ (AXP000117.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000117.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.